Stock comparison
ELI LILLY & Co is 777.4x more valuable than Xeris Biopharma Holdings, Inc. by market capitalization ($1.119 T vs $1.44 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 777.4x more valuable than Xeris Biopharma Holdings, Inc. by market capitalization ($1.119 T vs $1.44 B).
Market value leader
LLY
ELI LILLY & Co is 777.4x more valuable than Xeris Biopharma Holdings, Inc. by market capitalization ($1.119 T vs $1.44 B).
Revenue leader
LLY
XERS: $291.85M vs LLY: $65.18B.
Profit leader
LLY
XERS: $554.00K vs LLY: $20.64B.
Margin leader
LLY
XERS: 0.2% vs LLY: 31.7% net margin.
| Metric | XERS | LLY |
|---|---|---|
| Market cap | $1.44 B | $1.119 T |
| US-listed rank | #2387 | #10 |
| Revenue (latest FY) | $291.85M | $65.18B |
| Net income (latest FY) | $554.00K | $20.64B |
| Net margin | 0.2% | 31.7% |
| P/E (trailing FY) | 2599.0x | 54.2x |
| SEC filings | 290 | 1,000 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 777.4x more valuable than Xeris Biopharma Holdings, Inc. by market capitalization ($1.119 T vs $1.44 B).
In their latest fiscal years, Xeris Biopharma Holdings, Inc. reported $291.85M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Xeris Biopharma Holdings, Inc. and ELI LILLY & Co, or browse the full rankings.